We need to look at other players in the non-canonical signaling pathway cascade to ensure the complete inhibition of TGFβ signaling, thereby inhibiting the migration and invasive capability of the prostate cancer cells effectively. This evidence concerns the gene TGFB1 and prostate cancer.